Michael R Freeman

Title: Michael R Freeman: Innovator in Cholesterol Treatment

Introduction

Michael R Freeman is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of cholesterol-associated tumors. With a total of 5 patents to his name, Freeman's work has the potential to impact many lives.

Latest Patents

Freeman's latest patents focus on compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors. One of his key inventions provides a method for the prevention or treatment of cholesterol-associated tumors. This method involves administering a therapeutically effective amount of an azetidinone-based cholesterol absorption inhibitor, preferably ezetimibe (SCH 58235) or its phenolic glucuronide. The invention also includes formulations of ezetimibe for the prevention or treatment of cholesterol-associated tumors, which may further comprise at least one other anticancer agent. Additionally, an article of manufacture is provided, which includes a container, instructions, and a composition for the administration of the treatment.

Career Highlights

Throughout his career, Freeman has worked with reputable organizations such as Children's Medical Center Corporation and the Massachusetts Institute of Technology. His experience in these institutions has contributed to his expertise in the field of medical innovations.

Collaborations

Some of Freeman's notable coworkers include Marsha A Moses and Dmitri G Wiederschain. Their collaborative efforts have likely enhanced the quality and impact of his inventions.

Conclusion

Michael R Freeman is a distinguished inventor whose work in cholesterol treatment showcases his innovative spirit and dedication to improving healthcare. His contributions are paving the way for advancements in the treatment of cholesterol-associated tumors.